Press Releases

Huateng Pharma Develops A novel chemiluminescent Substrate APS-5

TransCelerate BioPharma Appoints Janice Chang as New CEO

CD Formulation Strengthens Its Role as a CRO Company for Pharmaceuticals

Combining robust expertise and years of experience, the US-based company CD Formulation further strengthens its role as a contract service provider for pharmaceutical companies in a recent statement.

Samsung Biologics unlocks additional capacity for production at its newest Plant 4

Oxilio and Quotient Sciences Announce Regulatory Approval for Oxilio’s OXL001 Development Program

Oxilio, a pioneering drug development company repurposing existing drugs to address unmet needs in cancer treatment, and Quotient Sciences, a drug development and manufacturing accelerator, today announced an update on the development of Oxilio’s OXL001 product.

Sharp Adds New Talent with Clinical Leadership Appointments

Sharp, a leading provider of pharmaceutical packaging and clinical services, has strengthened its clinical leadership team with the appointment of Robert Feltz as Director, Analytical and Formulation Services and Michael MacNeir as Vice President, Global Business Development.

High-Standard Fermented Raw Materials that Satisfy the Quality Attributes of Healthcare Products

BOC Sciences is able to provide clients with high-standard fermented raw materials that satisfy the quality attributes of finished healthcare products.

RBQM market leader, CluePoints, marks its tenth anniversary as ICH E6 (R3) looks set to mandate the company’s data-driven approach across all clinical trials

RBQM market leader, CluePoints, marks its tenth anniversary as ICH E6 (R3) looks set to mandate the company’s data-driven approach across all clinical trials Risk-Based Quality Management: A front row seat to a decade of transformation

BOC Sciences Rolled Out PEG GMP Manufacture Services for Broad Applications

BOC Sciences recently launched the PEG GMP manufacture service, a novel solution that aims at providing GMP-grade PEG products for a wide scope of applications.

BOC Sciences Honored To Assist in the Antibody Research With High-Quality Chemicals

BOC Sciences' chemical products have been applied in a wide range of research projects and helped achieve groundbreaking breakthroughs.

BOC Sciences Reports Its Antibody Modification and Conjugation Technologies in Detail

The chief technician of BOC Sciences ADC development center recently reported some detailed information regarding its antibody modification and conjugation technologies, bringing the audience and customers a better understanding of how BOC Sciences has contributed to the ADC industry.

BOC Sciences Declares the Availability of 10,000 Impurities, All in Stock!

BOC Sciences recently confirmed to its customers that over 10,000 impurities are now in stock, ready for immediate delivery.

MicrobioSeq Announces the Launch of the Phage Whole-Genome Sequencing Service

CD Genomics RNA-Solutions Platform Now Provides Whole Transcriptome Sequencing Service

CD Formulation Plays a Role in Developing Drug Delivery Systems

Alfa Chemistry Announces the Release of Extracted Peptides

Applications of Liposomal Drug Delivery System Technology

As Paradigm Clinical Research Expands, So Does the Executive Team

Paradigm Clinical Research (Paradigm), with three dedicated research sites in California and Colorado, announced it has grown its executive leadership team, bringing on board Travis Milnes as chief financial officer (CFO) and Amy Henderson as head of clinical operations.

Q² Solutions Launches Innovative Self-Collection Safety Lab Panel in Collaboration with Tasso

Q2 Solutions, a wholly owned subsidiary of IQVIA and a leading global clinical trial laboratory services organization, today announced the launch of the first self-collection safety lab panel for U.S. clinical trial participants by a leading global clinical trial laboratory.

Genezen delivers next phase of cGMP lentiviral and retroviral vector production facility expansion

Genezen has completed another expansion phase at its viral vector process development and cGMP vector production facility in Fishers, Indiana (US).